A. Gray

Interactions of Oversulfated Chondroitin Sulfate (OSCS) From Different Sources With Unfractionated Heparin

D. Hoppensteadt, J. Fareed, E. Litinas, 2012, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Antibody Desensitization Therapy in Highly Sensitized Lung Transplant Candidates

L. Snyder, G. Arepally, S. Palmer, 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Anticoagulant and Antithrombotic Actions of AVE5026, an Enriched Anti-Xa Hemisynthetic Ultra-Low-Molecular-Weight Heparin

D. Hoppensteadt, J. Fareed, W. Jeske, 2014, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Ultra-low-molecular-weight heparins: Precise structural features impacting specific anticoagulant activities

G. Sassaki, H. Nader, D. Hoppensteadt, 2013, Thrombosis and Haemostasis.

A common standard is inappropriate for determining the potency of ultra low molecular weight heparins such as semuloparin and bemiparin.

A. Bayol, J. Cunanan, J. Fareed, 2011, Thrombosis research.

Structural and Pharmacological Profile of Generic Enoxaparins Used in Brazil

G. Sassaki, H. Nader, D. Hoppensteadt, 2012, Clinical and applied thrombosis/hemostasis.